¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Primary progressive aphasia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • progressive resistance
    Á¡ÁõÀúÇ×
  • progressive resistance exercise
    Á¡ÁõÀúÇ׿
  • progressive spastic spinal paralysis
    ÁøÇà°­Á÷ô¼ö¸¶ºñ
  • progressive spinal amyotrophy
    ÁøÇàô¼ö±Ù(À°)À§Ãà(Áõ)
  • progressive spinal muscular atrophy
    ÁøÇàô¼ö¼º±Ù(À°)À§ÃàÁõ
  • progressive subcortical encephalopathy
    ÁøÇà°ÑÁú¹Ø³úº´(Áõ), ÁøÇàÇÇÁúÇϳúº´(Áõ)
  • progressive supranuclear palsy
    ÁøÇàÇٻ󸶺ñ
  • progressive systemic sclerosis
    ÁøÇàÀü½Å°æÈ­Áõ
  • rapidly progressive glomerulonephritis
    ±Þ¼ÓÁøÇàÅ丮ÄáÆÏ¿°, ±Þ¼ÓÁøÇà»ç±¸Ã¼½Å¿°
  • receptive aphasia
    ¼ö¿ë¼º¾ð¾î»ó½ÇÁõ, ¼ö¿ë¼º½Ç¾îÁõ
  • syntactical aphasia
    ¹®Àå¾ð¾î»ó½ÇÁõ, ¹®Àå½Ç¾îÁõ
  • semantic aphasia
    ¸»¶æ¸ð¸§¾ð¾î»ó½ÇÁõ, ¸»¶æ¸ð¸§½Ç¾îÁõ, ¾îÀǽǾîÁõ
  • sensory aphasia
    °¨°¢¾ð¾î»ó½ÇÁõ, °¨°¢½Ç¾îÁõ
  • tactile aphasia
    Ã˰¢¾ð¾î»ó½ÇÁõ, Ã˰¢½Ç¾îÁõ
  • verbal aphasia
    ¿îµ¿¾ð¾î»ó½ÇÁõ, ¿îµ¿½Ç¾îÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • progressive lingual hemiatrophy
    ÁøÇàÇô¹ÝÀ§ÃàÁõ
  • progressive diffuse keratoderma
    ±¤¹üÀ§ÁøÇà°¢ÁúÇǺÎÁõ
  • progressive cardiomyopathic lentiginosis
    ÁøÇà½ÉÀå±ÙÀ°º´Èæ»öÁ¡Áõ
  • progressive multifocal leukoencephalopathy
    ÁøÇà´ÙÃÊÁ¡¹é»öÁú³úÁõ
  • progressive mean
    ´©°¡Æò±Õ
  • progressive myopia
    ÁøÇà±Ù½Ã
  • progressive hypertrophic interstitial neuritis
    ÁøÇàºñ´ë»çÀÌÁú½Å°æ¿°
  • progressive nuclear ophthalmoplegia
    ÁøÇà½Å°æÇÙ´«±ÙÀ°¸¶ºñ
  • progressive
    ÁøÇà-
  • progressive bulbar palsy
    ÁøÇà¼û³ú¸¶ºñ, ÁøÇ౸¸¶ºñ
  • progressive resistance
    Á¡ÁõÀúÇ×
  • progressive thrombus
    ÁøÇàÇ÷Àü
  • progressive spastic spinal paralysis
    ÁøÇà°æÁ÷ô¼ö¸¶ºñ
  • progressive systemic sclerosis
    (¢¡systemic scleroderma) Àü½ÅÇǺΰæÈ­Áõ
  • primary action
    ÀÏÂ÷ÀÛ¿ë, ÀÏÂ÷±â´É
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • progressive facial paralysis
    ÁøÇà(¼º) ¾È¸é¸¶ºñ
  • progressive hypertrophic interstitial neuritis
    ÁøÇ༺ ºñÈļº °£Áú¼º ½Å°æ¿°(¡­ãêÌèæú).
  • progressive hypertrophic interstitial neuritis
    ÁøÇ༺ ºñÈļº °£Áú¼º ½Å°æ¿°(òäú¼àõ Ýþý§àõ ÊÖòðàõ ãêÌèæú)
  • progressive idiopathic atrophoderma
    ÁøÇ༺ ¿øÀÎºÒ¸í¼º ÇǺΠÀ§ÃàÁõ
  • progressive lenticular degeneration
    ÁøÇ༺ ·»ÁîÇÙº¯¼º(Áõ)(òäú¼àõ¡­ú·Ü¨àõ(ñø))
  • progressive lingual hemiatrophy
    ÁøÇà(¼º) ¹ÝÃø¼³À§ÃàÁõ
  • progressive lingual hemiatrophy
    ÁøÇ༺ ¹ÝÃø¼³À§ÃàÁõ(òäú¼àõ Úâö°àßê×õêñø)
  • progressive lipodystrophy
    ÁøÇ༺ Áö¹æÀÌ¿µ¾çÁõ.
  • progressive lipodystrophy
    ÁøÇ༺ Áö¹æÀÌ¿µ¾çÁõ(òäú¼àõ ò·Û¸ì¶ç½å×ñø)
  • progressive mean
    ´©°¡Æò±Õ(ËÈ˧̰˻).
  • progressive multifocal leukoencephalopathy
    ÁøÇ༺ ´Ù¹ß¼º ¹éÁú³ú(º´)Áõ
  • progressive multifocal leukoencephalopathy
    ÁøÇ༺ ´ÙÃÊÁ¡¼º ¹éÁú³úº´Áõ(òäú¼àõ Òýõ¥ïÇàõ ÛÜòõÒàÜ»ñø)
  • progressive muscle dystrophy
    ÁøÇ༺ ±ÙÀÌ¿µ¾çÁõ(òäú¼àõÐÉì¶ç½å×ñø).
  • progressive muscle dystrophy
    ÁøÇ༺ ±ÙÀÌ¿µ¾çÁõ(òäú¼àõ ì¶ç½å×ñø)
  • progressive myopathy
    ÁøÇ༺ ±Ùº´Áõ(¡­ÐÉÜ»ñø).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • progressive lingual hemiatrophy
    ÁøÇ༺ ¹ÝÃø¼³À§ÃàÁõ(òäú¼àõ Úâö°àßê×õêñø)
  • progressive lipodystrophy
    ÁøÇ༺ Áö¹æÀÌ¿µ¾çÁõ.
  • progressive lipodystrophy
    ÁøÇ༺ Áö¹æÀÌ¿µ¾çÁõ(òäú¼àõ ò·Û¸ì¶ç½å×ñø)
  • progressive mean
    ´©°¡Æò±Õ(ËÈ˧̰˻).
  • progressive multifocal leukoencephalopathy
    ÁøÇ༺ ´Ù¹ß¼º ¹éÁú³ú(º´)Áõ
  • progressive multifocal leukoencephalopathy
    ÁøÇ༺ ´ÙÃÊÁ¡¼º ¹éÁú³úº´Áõ(òäú¼àõ Òýõ¥ïÇàõ ÛÜòõÒàÜ»ñø)
  • progressive muscle dystrophy
    ÁøÇ༺ ±ÙÀÌ¿µ¾çÁõ(òäú¼àõÐÉì¶ç½å×ñø).
  • progressive muscle dystrophy
    ÁøÇ༺ ±ÙÀÌ¿µ¾çÁõ(òäú¼àõ ì¶ç½å×ñø)
  • progressive myoclonic epilepsies
  • progressive myopathy
    ÁøÇ༺ ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • progressive myopathy
    ÁøÇ༺ ±Ùº´Áõ(òäú¼àõ ÐÉÜ»ñø)
  • progressive myopia
    ÁøÇ༺ ±Ù½Ã(òäú¼àõ ÐÎãÊ) ¾Æµ¿ÀÇ
  • progressive neural muscular atrophy
    ÁøÇ༺ ½Å°æ¼º ±ÙÀ§Ãà(¡­ãêÌèàõÐÉê×õê).
  • progressive neural muscular atrophy
    ÁøÇ༺ ½Å°æ¼º ±ÙÀ§Ãà(òäú¼àõ ãêÌèàõ ÐÉê×õê)
  • progressive nodular fibrosis of the skin
    ÁøÇ༺ °áÀý ÇǺΠ¼¶À¯Áõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
PHC personal health costs; posthospital care; premolar hypodontia, hyperhidrosis, [premature] canities [...
PI first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;...
AAT Aachen Aphasia Test; academic aptitude test; alanine aminotransferase; alkylating agent therapy; alp...
ALPS angiolymphoproliferative syndrome; Aphasia Language Performance Scale; attitudinal listening profile...
Aph aphasia
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
PR Progressive Ratio
PSP Progressive supranuclear paly
PSS Progressive Systemic Scleroderma
PSS Progressive Systemic Sclerosis
PEO Progressive external ophthalmoplegia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • optic aphasia
    ½Ã°¢¼º ½Ç¾î, ½Ã°¢¼º ½Ç¾îÁõ
    ¾ð¾î ÁßÃß¿Í ½Ã°¢ ÁßÃß°£ÀÇ ¿¬¶ô Àå¾Ö¿¡ ÀÇÇØ ÀϾ¸ç º¸ÀÌ´Â ¹°Ã¼ÀÇ ¸íĪÀ» ¸»ÇÏÁö ¸øÇÏ´Â ½Ç¾îÁõ.
  • semantic aphasia
    ¹®ÀÇ ½Ç¾î, ¹®ÀÇ ½Ç¾îÁõ, ¾îÀÇ ½Ç¾î
    ´Ü¾î¿Í ¾î±¸ÀÇ ¶æÀ» ¸ð¸£°Å³ª ȤÀº ±â¾ïÇÏÁö ¸øÇÏ´Â ½Ç¾î.
  • syntactical aphasia
    ¹®Àå ½Ç¾î
    ¾ð¾î¸¦ ÀûÀýÈ÷ ¹è¿­ÇÏÁö ¸øÇÏ´Â ½Ç¾îÁõ. µû¶ó¼­ ȯÀڴ Ⱦ¼³¼ö¼³ÇÏ°Ô µÈ´Ù.
  • tactile aphasia
    Ã˰¢ ½Ç¾î
    ¸ö¿¡ ´ê´Â ¹°°ÇÀÇ À̸§À» ¸»ÇÏÁö ¸øÇÏ´Â °Í.
  • total aphasia
    Àü½Ç¾îÁõ
  • true aphasia
    Áø¼º ½Ç¾î
    ¾ð¾î ÁßÃß Áß ¾î¶² ÇϳªÀÇ º´º¯¿¡ ÀÇÇÑ ½Ç¾îÁõ.
  • Wernicke's aphasia
    º£¸£´ÏÄÉ ½Ç¾îÁõ
  • A alpha primary afferent
    A ¾ËÆÄ ÀÏÂ÷ ±¸½É ½Å°æ
    ±Ù¹æÃß ³»ÀÇ ±Ù ¼¶À¯¿¡ Á¸ÀçÇÏ´Â °¨°¢½Å°æÀÇ Çϳª·Î ¥°a °¨°¢ ½Å°æÀ̶ó°íµµ ÇÑ´Ù. Á÷°æÀº 22§­, Àüµµ ¼Óµµ´Â 120§½ÀÌ´Ù.
  • C primary afferent nociceptor
    C ÀÏÂ÷ ±¸½É¼º Ä§ÇØ ¼ö¿ëü, C ÀÏÂ÷ ±¸½É¼º À¯ÇØ ¼ö¿ë±â
  • early primary closure
    Á¶±â 1Â÷ ºÀÇÕ
  • ensitization 1. administration of antigen to induce a primary immune response; priming; immunization. 2. exposure to allergen that results in the development of hypersensitivity. 3. the coating of erythrocytes with antibody so that they are subject to lys
    ³»¹ø
    ƯÈ÷ ¾È°Ë ¿¬ÀÇ.
  • myelinated primary afferent
    ÀÏÂ÷ À¯¼öÃÊ ±¸½É ½Å°æ
  • nociceptive primary afferent
    Ä§ÇØ ¼ö¿ë¼º ÀÏÂ÷ ±¸½É ½Å°æ, À¯ÇØ ¼ö¿ë¼º ÀÏÂ÷ ±¸½É ½Å°æ
  • non-nociceptive A delta C primary afferent
    ºñÄ§ÇØ ¼ö¿ë¼º A µ¨Å¸ C ÀÏÂ÷ ±¸½É ½Å°æ, ºñÀ¯ÇØ ¼ö¿ë¼º A µ¨Å¸ C ÀÏÂ÷ ±¸½É ½Å°æ
  • non-nociceptive myelinated primary afferent
    ºñÄ§ÇØ ¼ö¿ë¼º ÀÏÂ÷ ±¸½É ¼¶À¯, ºñÀ¯ÇØ ¼ö¿ë¼º ÀÏÂ÷ ±¸½É ¼¶À¯
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
chronic progressive syphilitic meningoencephalitis Syphilitic infection manifested as dementia (often with delusional features), dysarthria, seizures, myoclonic jerks, action tremor, impaired walking and standing, pupillary abnormalities, and abnormal CSF findings.
Synonym: chronic progressive syphilitic meningoencephalitis.
(05 Mar 2000)
pneumonia, progressive interstitial, of sheep Chronic respiratory disease caused by the visna-maedi virus. It was formerly believed to be identical with jaagsiekte (pulmonary adenomatosis, ovine) but is now recognised as a separate entity.
(12 Dec 1998)
progressive Advancing, going forward, going from bad to worse, increasing in scope or severity.
(18 Nov 1997)
progressive bacterial synergistic gangrene Undermining ulcer of the skin and subcutaneous tissues, usually following an operation, caused by a synergistic interaction between microaerophilic nonhemolytic streptococci and aerobic haemolytic staphylococci.
Synonym: Meleney's gangrene, progressive bacterial synergistic gangrene.
(05 Mar 2000)
progressive bulbar palsy One of the subgroups of motor neuron disease; a progressive degenerative disorder of the motor neurons of primarily the brainstem, manifested as weakness (and wasting) of the various bulbar muscles, resulting in dysarthria and dysphagia-fluid regurgitation is an outstanding symptom and can cause aspiration; tongue weakness and wasting is usually evident, and often the fasciculation potentials are present in the tongue and facial muscles.
Synonym: glossopalatolabial paralysis, glossopharyngeolabial paralysis.
(05 Mar 2000)
progressive bulbar paralysis Progressive weakness and atrophy of the muscles of the tongue, lips, palate, pharynx, and larynx, usually occurring in later life; most often caused by motor neuron disease.
Synonym: bulbar palsy, bulbar paralysis, Duchenne's disease, Erb disease, glossolabiolaryngeal paralysis, glossolabiopharyngeal paralysis.
(05 Mar 2000)
progressive cataract A cataract in which the opacification process progresses to involve the entire lens.
(05 Mar 2000)
progressive cerebellar tremor <syndrome> An intention tremor beginning in one extremity, gradually increasing in intensity, and subsequently involving other parts of the body.
Synonym: progressive cerebellar tremor.
Facial paralysis, otalgia, and herpes zoster resulting from viral infection of the seventh cranial nerve and geniculate ganglion, a form of juvenile paralysis agitans associated with primary atrophy of the pallidal system.
Synonym: paleostriatal syndrome, pallidal syndrome.
Synonym: Ramsay Hunt's syndrome.
(05 Mar 2000)
progressive cerebral poliodystrophy Familial progressive spastic paresis of extremities with progressive mental deterioration, with development of seizures, blindness and deafness, beginning during the first year of life, and with destruction and disorganization of nerve cells of the cerebral cortex.
Synonym: Alpers disease, Christensen-Krabbe disease, progressive cerebral poliodystrophy.
(05 Mar 2000)
progressive choroidal atrophy An x chromosome-linked abnormality characterised by atrophy of the choroid and degeneration of the retinal pigment epithelium causing night blindness.
(12 Dec 1998)
progressive circumscribed cerebral atrophy Circumscribed atrophy of the cerebral cortex.
Synonym: lobar sclerosis, progressive circumscribed cerebral atrophy.
(05 Mar 2000)
progressive cleavage In fungi, a type of sporulation in which cleavage planes in the cytoplasm first produce protospores and then sporangiospores in a sporangium.
(05 Mar 2000)
progressive emphysematous necrosis <microbiology> A severe form of gangrene (tissue necrosis) caused by Clostridium infection. Also referred to as necrotising subcutaneous infection.
Results in death of the subcutaneous tissues and muscle layers.
See: necrotising fascitis.
(27 Sep 1997)
progressive familial scleroderma A syndrome characterised by calcinosis cutis, Raynaud's phenomenon, sclerodactyly, and telangiectasia; usually due to scleroderma; autosomal dominant form of progressive systemic sclerosis.
(05 Mar 2000)
progressive hypertrophic polyneuropathy A familial type of demyelinating sensorimotor polyneuropathy that begins in early childhood and is slowly progressive; clinically characterised by foot pain and paresthesias, followed by symmetrical weakness and wasting of the distal limbs; one of the causes of stork legs; patients are wheelchair bound at an early age; peripheral nerves are palpably enlarged and non-tender; pathologically, onion bulb formation is seen in the nerves: whorls of overlapping, intertwined Schwann cell processes that encircle bare axons; usually autosomal recessive inheritance.
Synonym: Dejerine's disease, progressive hypertrophic polyneuropathy.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • primary wall
    (¼¼Æ÷¸·ÀÇ) 1Â÷¸·
  • runoff primary
    °á¼± ÅõÇ¥(µÎ ÃÖ°í µæÇ¥ÀÚÁß Áö¸í È帰¡ µÉ »ç¶÷À» Á¤ÇÏ´Â)
  • white primary
    ¹éÀÎ ¿¹¼±È¸(¹Ì±¹ ³²ºÎ ¿©·¯ ÁÖÀÇ ¹éÀθ¸ÀÌ ÅõÇ¥ÇÏ´ø ¹ÎÁÖ´çÀÇ ¿¹ºñ ¼±°Å)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á